Literature DB >> 10582609

Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

J Wiltfang1, M Otto, H C Baxter, M Bodemer, P Steinacker, E Bahn, I Zerr, J Kornhuber, H A Kretzschmar, S Poser, E Rüther, A Aitken.   

Abstract

Two-dimensional polyacrylamide gel electrophoresis of CSF has been used in the diagnosis of Creutzfeldt-Jakob disease (CJD). One of the two diagnostic protein spots was identified as isoform(s) of the 14-3-3 family of abundant brain proteins. This has led to the development of one-dimensional 14-3-3 sodium dodecyl sulfate polyacrylamide gel electrophoresis immunoblot, which is currently used to support the diagnosis of CJD. In the present study employing western blot analysis, we have identified the panel of 14-3-3 isoforms that appear in the CSF of 10 patients with CJD compared with 10 patients with other dementias. The results clearly show that the 14-3-3 isoforms beta, gamma, epsilon, and eta are present in the CSF of patients with CJD and can be used to differentiate other dementias. 14-3-3eta also gave a baseline signal in all patients with other dementias, including six patients with Alzheimer's disease. The presence of 14-3-3eta in the CSF of a patient with herpes simplex encephalitis was particularly noteworthy. This study has determined that isoform-specific 14-3-3 antibodies against beta, gamma, and epsilon should be considered for the neurochemical differentiation of CJD from other neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10582609     DOI: 10.1046/j.1471-4159.1999.0732485.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  25 in total

Review 1.  Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants.

Authors:  Alastair Aitken
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

2.  14-3-3 proteins in neurological disorders.

Authors:  Molly Foote; Yi Zhou
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

3.  Structural basis for protein-protein interactions in the 14-3-3 protein family.

Authors:  Xiaowen Yang; Wen Hwa Lee; Frank Sobott; Evangelos Papagrigoriou; Carol V Robinson; J Günter Grossmann; Michael Sundström; Declan A Doyle; Jonathan M Elkins
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-03       Impact factor: 11.205

4.  Detection of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease Patients Using a New Automated Capillary Western Assay.

Authors:  A Fourier; A Dorey; A Perret-Liaudet; I Quadrio
Journal:  Mol Neurobiol       Date:  2017-05-16       Impact factor: 5.590

Review 5.  14-3-3s are potential biomarkers for HIV-related neurodegeneration.

Authors:  Diana Morales; Efthimios C M Skoulakis; Summer F Acevedo
Journal:  J Neurovirol       Date:  2012-07-19       Impact factor: 2.643

6.  Downregulation of 14-3-3 Proteins in a Kainic Acid-Induced Neurotoxicity Model.

Authors:  Danyal Smani; Sumit Sarkar; James Raymick; Jyotshna Kanungo; Merle G Paule; Qiang Gu
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

7.  The 14-3-3 protein epsilon isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes.

Authors:  Jun-Ichi Satoh; Takashi Yamamura; Kunimasa Arima
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 8.  Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer's disease and other neurodegenerative dementias.

Authors:  J Genius; H Klafki; J Benninghoff; H Esselmann; J Wiltfang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-18       Impact factor: 5.270

9.  Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death.

Authors:  Hyung-Wook Kim; Yunyoung C Chang; Mei Chen; Stanley I Rapoport; Jagadeesh S Rao
Journal:  BMC Neurosci       Date:  2009-09-28       Impact factor: 3.288

10.  Mutations at codons 178, 200-129, and 232 contributed to the inherited prion diseases in Korean patients.

Authors:  Bo-Yeong Choi; Su Yeon Kim; So-Young Seo; Seong Soo A An; Sangyun Kim; Sang-Eun Park; Seung-Han Lee; Yun-Ju Choi; Sang-Jin Kim; Chi-Kyeong Kim; Jun-Sun Park; Young-Ran Ju
Journal:  BMC Infect Dis       Date:  2009-08-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.